Outcome of 33rd Annual General Meeting held today i.e. 29th September, 2025 in terms of Regulation 30(6) of the SEBI(LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Limited held its 33rd Annual General Meeting on 29th September 2025 via video conferencing, which ran from 4:08 PM to 4:26 PM. The meeting was chaired by Managing Director Vishwambar Kameshwar Singh, with Company Secretary Yukta Patel conducting the proceedings. Seven resolutions were tabled: adoption of audited financials for FY ending 31st March 2025 and re-appointment of the Managing Director (ordinary), plus five special resolutions covering appointment of a new independent director, higher borrowing limits under Section 180(1)(c), authority to sell or dispose of company undertakings, loan/guarantee authorisation under Section 186, and loans to directors under Section 185. No shareholder questions were raised during the meeting. E-voting results will be declared within two working days.
The AGM outcome is largely procedural, but the special resolutions on expanded borrowing powers, asset disposal authority, and loans to directors give the board significant financial flexibility that shareholders should monitor. Pending e-voting results will confirm whether these expanded powers were approved by the required majority.